abstract gray background

Search Results

Found 67 results for label/Diskusi.

PPD | Post
Moving Toward the Implementation Deadline — Approaching MDR Compliance

Industry reports indicate many companies still seem unprepared as they struggle to understand MDR compliance. Learn more about how to comply.

Read More
PPD | Post
Estimands in Oncology Trials

PPD’s cross-functional estimands working group explores how the ICH E9 addendum impacts oncology clinical trials.

Read More
PPD | Post
The Value of Patient Experience Data

Qualitative interviews can generate meaningful patient data to inform trial design and gain deeper understanding of treatment experience.

Read More
PPD | Post
European Union Clinical Trials Regulation: Clinical Trials Information System

PPD experts explain the key features of the Clinical Trials Information System (CTIS), which has been introduced alongside the new EU CTR.

Read More
PPD | Post
The Present and Future of Conditional Regulatory Authorization and Access Pathways for ATMPs

Advanced Therapy Medicinal Products (ATMPs) are some of the most technologically innovative treatments today. Explore the authorization and access landscape. 

Read More
PPD | Our Solutions
FSP Quality Assurance

PPD FSP quality assurance solutions help biotech, biopharmaceutical and medical device companies to ensure the safety and integrity of clinical trials.

Read More
PPD | Post
Virtual Support Improves Patient, Site and Sponsor Experiences in Clinical Trials

Learn how virtual support can help address challenges that patients and sites may face in clinical trials.

Read More